Noxopharm Limited
ASX:NOX.AX
0.13 (AUD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 2.32 | 3.009 | 14.011 | 26.796 | 7.1 | 2.91 | 12.614 | 2.458 | 6.178 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Cash and Short Term Investments
| 2.32 | 3.009 | 14.011 | 26.796 | 7.1 | 2.91 | 12.614 | 2.458 | 6.178 |
| Net Receivables
| 2.404 | 6.085 | 5.213 | 5.799 | 4.647 | 0 | 0.123 | 0.063 | 0.006 |
| Inventory
| -2.359 | 0 | 1.146 | 0.312 | 0.519 | 0.696 | 1.269 | 0 | 0 |
| Other Current Assets
| 0.045 | 0.066 | 0.463 | 0.068 | 0.063 | 0.282 | 0.071 | 0.047 | 0.007 |
| Total Current Assets
| 4.768 | 9.159 | 20.833 | 32.974 | 12.329 | 3.888 | 14.076 | 2.567 | 6.191 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 0.006 | 0.007 | 0.222 | 0.484 | 0.851 | 0.257 | 0.318 | 0.064 | 0.005 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0.037 | 0.037 | 0.001 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0.037 | 0.037 | 0.001 | 0 |
| Long Term Investments
| 2.01 | 0.962 | 5.539 | 14.395 | 6.887 | 0.119 | 0.119 | 0.001 | 0.012 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0.175 | 0.236 | -0.001 | 0 |
| Other Non-Current Assets
| 0 | -0.969 | -0 | -0 | -0 | -0.294 | -0.355 | 0.196 | 0 |
| Total Non-Current Assets
| 2.015 | 0.969 | 5.76 | 14.88 | 7.738 | 0.294 | 0.355 | 0.261 | 0.017 |
| Total Assets
| 6.784 | 10.128 | 26.594 | 47.854 | 20.067 | 4.3 | 14.549 | 2.829 | 6.208 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 0.649 | 0.448 | 0.81 | 6.13 | 1.787 | 1.487 | 0.887 | 0.291 | 0.252 |
| Short Term Debt
| 0 | 0 | 0.161 | 0.232 | 4.587 | 3.93 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | -3.93 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.597 | 0.514 | 1.31 | 0.445 | 0.312 | 4.264 | 0.235 | 0.07 | 0.009 |
| Total Current Liabilities
| 1.246 | 0.962 | 2.281 | 6.807 | 6.686 | 5.751 | 1.122 | 0.361 | 0.262 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0 | 0 | 0 | 0.118 | 0.413 | 0 | 3.279 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.042 | 0.093 | 0.195 | 0.152 | 0.095 | 0 | -3.279 | 0.291 | 0.252 |
| Total Non-Current Liabilities
| 0.042 | 0.093 | 0.195 | 0.27 | 0.509 | 0 | 3.279 | 0.291 | 0.252 |
| Total Liabilities
| 1.289 | 1.055 | 2.476 | 7.077 | 7.194 | 5.751 | 4.401 | 0.361 | 0.262 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.015 |
| Common Stock
| 74.636 | 74.636 | 74.636 | 72.623 | 41.631 | 28.701 | 28.449 | 6.218 | 6.352 |
| Retained Earnings
| -70.07 | -72.061 | -58.803 | -40.333 | -31.466 | -33.257 | -22.034 | -3.751 | -0.6 |
| Accumulated Other Comprehensive Income/Loss
| 0.93 | 6.498 | 8.285 | 8.487 | 2.708 | 4.455 | 3.733 | 0 | 0.194 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.015 |
| Total Shareholders Equity
| 5.495 | 9.073 | 24.118 | 40.776 | 12.873 | -0.101 | 10.148 | 2.468 | 5.946 |
| Total Equity
| 5.495 | 9.073 | 24.118 | 40.776 | 12.873 | -1.45 | 10.148 | 2.468 | 5.946 |
| Total Liabilities & Shareholders Equity
| 6.784 | 10.128 | 26.594 | 47.854 | 20.067 | 4.3 | 14.549 | 2.829 | 6.208 |